Mark J Foley - Net Worth and Insider Trading

Mark J Foley Net Worth

The estimated net worth of Mark J Foley is at least $21 Million dollars as of 2024-11-13. Mark J Foley is the President and CEO of ZELTIQ Aesthetics Inc and owns about 211,454 shares of ZELTIQ Aesthetics Inc (ZLTQ) stock worth over $12 Million. Mark J Foley is the Director of Glaukos Corp and owns about 33,220 shares of Glaukos Corp (GKOS) stock worth over $5 Million. Mark J Foley is also the CEO of Revance Therapeutics Inc and owns about 1,126,381 shares of Revance Therapeutics Inc (RVNC) stock worth over $5 Million. Details can be seen in Mark J Foley's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark J Foley has not made any transactions after 2024-03-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Mark J Foley

To

Mark J Foley Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark J Foley owns 4 companies in total, including Revance Therapeutics Inc (RVNC) , SI-BONE Inc (SIBN) , and Glaukos Corp (GKOS) among others .

Click here to see the complete history of Mark J Foley’s form 4 insider trades.

Insider Ownership Summary of Mark J Foley

Ticker Comapny Transaction Date Type of Owner
RVNC Revance Therapeutics Inc 2024-03-06 director
SIBN SI-BONE Inc 2019-06-13 director
GKOS Glaukos Corp 2024-02-23 director
LIMIT LIMIT 2017-04-28 director & President and CEO

Mark J Foley Latest Holdings Summary

Mark J Foley currently owns a total of 3 stocks. Among these stocks, Mark J Foley owns 211,454 shares of ZELTIQ Aesthetics Inc (ZLTQ) as of March 13, 2017, with a value of $12 Million and a weighting of 55.9%. Mark J Foley owns 33,220 shares of Glaukos Corp (GKOS) as of February 23, 2024, with a value of $5 Million and a weighting of 22.33%. Mark J Foley also owns 1,126,381 shares of Revance Therapeutics Inc (RVNC) as of March 6, 2024, with a value of $5 Million and a weighting of 21.77%.

Latest Holdings of Mark J Foley

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZLTQ ZELTIQ Aesthetics Inc 2017-03-13 211,454 56.48 11,942,922
GKOS Glaukos Corp 2024-02-23 33,220 143.63 4,771,389
RVNC Revance Therapeutics Inc 2024-03-06 1,126,381 4.13 4,651,954

Holding Weightings of Mark J Foley


Mark J Foley Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark J Foley has made a total of 0 transactions in ZELTIQ Aesthetics Inc (ZLTQ) over the past 5 years. The most-recent trade in ZELTIQ Aesthetics Inc is the sale of 10,000 shares on March 13, 2017, which brought Mark J Foley around $557,700.

According to the SEC Form 4 filings, Mark J Foley has made a total of 1 transactions in Glaukos Corp (GKOS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Glaukos Corp is the sale of 4,560 shares on February 23, 2024, which brought Mark J Foley around $423,487.

According to the SEC Form 4 filings, Mark J Foley has made a total of 7 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years, including 2 buys and 5 sells. The most-recent trade in Revance Therapeutics Inc is the acquisition of 30,000 shares on March 6, 2024, which cost Mark J Foley around $209,400.

Insider Trading History of Mark J Foley

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark J Foley Trading Performance

GuruFocus tracks the stock performance after each of Mark J Foley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark J Foley is -6.03%. GuruFocus also compares Mark J Foley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark J Foley within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark J Foley's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark J Foley

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.25 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.02 LIMIT LIMIT LIMIT LIMIT LIMIT

Mark J Foley Ownership Network

Ownership Network List of Mark J Foley

No Data

Ownership Network Relation of Mark J Foley

Insider Network Chart

Mark J Foley Owned Company Details

What does Revance Therapeutics Inc do?

Who are the key executives at Revance Therapeutics Inc?

Mark J Foley is the director of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include Chief Financial Officer Tobin Schilke , President Dustin S Sjuts , and SVP & GC & Secretary Dwight Moxie .

Revance Therapeutics Inc (RVNC) Insider Trades Summary

Over the past 18 months, Mark J Foley made 5 insider transaction in Revance Therapeutics Inc (RVNC) with a net sale of 124,284. Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 35,664 shares made by Tobin Schilke , a net sale of 64,379 shares made by Dwight Moxie , and a net sale of 35,226 shares made by Dustin S Sjuts .

In summary, during the past 3 months, insiders sold 0 shares of Revance Therapeutics Inc (RVNC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,445 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 264,445 shares.

Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Revance Therapeutics Inc Insider Transactions

No Available Data

Mark J Foley Mailing Address

Above is the net worth, insider trading, and ownership report for Mark J Foley. You might contact Mark J Foley via mailing address: Zeltiq Aesthetics Inc., 4698 Willow Road Suite 100, Pleasanton Ca 94588.